Royce & Associates LP grew its position in shares of Caleres, Inc. (NYSE:CAL – Free Report) by 27.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 804,378 shares of the textile maker’s stock after purchasing an additional 172,568 shares during the quarter. Royce & Associates LP owned approximately 2.39% of Caleres worth $18,629,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of the company. Franklin Resources Inc. raised its holdings in shares of Caleres by 1.7% during the 3rd quarter. Franklin Resources Inc. now owns 27,905 shares of the textile maker’s stock valued at $908,000 after buying an additional 479 shares in the last quarter. Quest Partners LLC raised its holdings in shares of Caleres by 6.6% during the 3rd quarter. Quest Partners LLC now owns 14,028 shares of the textile maker’s stock valued at $464,000 after buying an additional 869 shares in the last quarter. Smartleaf Asset Management LLC raised its holdings in shares of Caleres by 254.4% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,733 shares of the textile maker’s stock valued at $40,000 after buying an additional 1,244 shares in the last quarter. Public Sector Pension Investment Board lifted its stake in Caleres by 2.5% in the third quarter. Public Sector Pension Investment Board now owns 74,539 shares of the textile maker’s stock worth $2,464,000 after purchasing an additional 1,800 shares during the last quarter. Finally, Golden State Wealth Management LLC purchased a new stake in Caleres during the fourth quarter valued at about $59,000. 98.44% of the stock is owned by hedge funds and other institutional investors.
Caleres Stock Performance
Shares of Caleres stock opened at $15.48 on Monday. The company’s 50 day moving average price is $18.11 and its 200-day moving average price is $26.22. Caleres, Inc. has a 52-week low of $15.00 and a 52-week high of $44.51. The stock has a market capitalization of $520.71 million, a price-to-earnings ratio of 3.45 and a beta of 1.82.
Caleres Announces Dividend
Analyst Ratings Changes
Separately, Loop Capital lowered their target price on Caleres from $30.00 to $25.00 and set a “hold” rating for the company in a research note on Friday, December 6th.
Insider Buying and Selling at Caleres
In related news, Director Kyle Gendreau purchased 5,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average cost of $19.93 per share, with a total value of $99,650.00. Following the completion of the purchase, the director now directly owns 5,000 shares in the company, valued at approximately $99,650. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 3.80% of the stock is currently owned by corporate insiders.
Caleres Profile
Caleres, Inc engages in the retail and wholesale of footwear business in the United States, Canada, East Asia, and internationally. It operates through Famous Footwear and Brand Portfolio segments. The company offers licensed, branded, and private-label athletic, casual, and dress footwear products. The company provides brand name athletic, casual, and dress shoes, including Nike, Skechers, adidas, Vans, Crocs, Converse, Puma, Birkenstock, New Balance, Under Armour, Dr.
Featured Articles
- Five stocks we like better than Caleres
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- How to Build the Ultimate Everything ETF Portfolio
- What is the FTSE 100 index?
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Most Volatile Stocks, What Investors Need to Know
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Caleres Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caleres and related companies with MarketBeat.com's FREE daily email newsletter.